StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) stock

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3013% below fair value
$8.32−0.18 (-2.12%)

Close on Nov 17, 2026Market cap $560.27MP/E –Yield –

Ginkgo Bioworks pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Ginkgo Bioworks

Ginkgo Bioworks has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Ginkgo Bioworks figures

See a number that looks wrong?